ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
06 avr. 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2023 on...
ResMed Chief Administrative Officer and Global General Counsel to Retire
30 mars 2023 16h05 HE
|
ResMed Inc.
ResMed to conduct an internal search for a successor general counselAmy Wakeham appointed Chief Communications and Investor Relations Officer, will join ResMed’s executive leadership team SAN DIEGO,...
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
15 mars 2023 16h19 HE
|
ResMed Inc.
SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life...
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
13 mars 2023 07h00 HE
|
ResMed Inc.
81% of respondents experience one or more symptoms indicating poor sleep quality, despite 64% saying they’re satisfied with the quantity of their sleepWomen and older generations are less satisfied...
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
07 mars 2023 09h00 HE
|
ResMed Inc.
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 33rd Annual Healthcare...
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
26 janv. 2023 16h05 HE
|
ResMed Inc.
Year-over-year revenue grows 16%, operating profit up 13%, non-GAAP operating profit up 14% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today...
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
26 janv. 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael (“Mick”) Farrell as chair of the...
ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023
12 janv. 2023 09h00 HE
|
ResMed Inc.
SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2023 on...
ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference
02 janv. 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, Jan. 02, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on...
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
22 nov. 2022 09h00 HE
|
ResMed Inc.
- Acquisition expands ResMed’s SaaS business to Germany, first non-U.S. market - Outpatient therapy services added to ResMed’s growing SaaS offering portfolio - Purchase price of €958.6 million...